Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine combined with remimazolam versus esketamine combined with propofol for thoracoscopic partial pulmonary resection
ChiCTR2500104188Phase 4Completed
- Sponsor
- Changzhou First People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine, remimazolam and propofol (2 arms), sponsored by Changzhou First People's Hospital. Primary endpoints: Mean arterial pressure, Heart rate and 2 more. Started Dec 2024; status: completed.
02
Drugs
esketamineremimazolampropofol
Beyond the preview
Go deeper on ChiCTR2500104188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104188.